Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
Keyword(s):
2011 ◽
Vol 31
(12)
◽
pp. 1192-1207
◽
2016 ◽
Vol 12
(4)
◽
pp. 330-335
◽
2015 ◽
Vol 18
(4)
◽
pp. 517
◽
2012 ◽
Vol 7
(3)
◽
pp. 175-194
◽